Your browser doesn't support javascript.
loading
Bronchodilator reversibility in asthma and COPD: findings from three large population studies.
Janson, Christer; Malinovschi, Andrei; Amaral, Andre F S; Accordini, Simone; Bousquet, Jean; Buist, A Sonia; Canonica, Giorgio Walter; Dahlén, Barbro; Garcia-Aymerich, Judith; Gnatiuc, Louisa; Kowalski, Marek L; Patel, Jaymini; Tan, Wan; Torén, Kjell; Zuberbier, Torsten; Burney, Peter; Jarvis, Deborah.
Afiliación
  • Janson C; Dept of Medical Sciences, Respiratory Allergy and Sleep Research, Uppsala University, Uppsala, Sweden christer.janson@medsci.uu.se.
  • Malinovschi A; Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College London, London, UK.
  • Amaral AFS; Dept of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.
  • Accordini S; Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College London, London, UK.
  • Bousquet J; Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Buist AS; Fondation FMC VIA-LR, Montpellier, France.
  • Canonica GW; Euforea, Brussels, Belgium.
  • Dahlén B; Allergy Centre Charité, Dept of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Garcia-Aymerich J; Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR, USA.
  • Gnatiuc L; Personalized Medicine Clinic Asthma and Allergy Humanitas Research Hospital, Milan, Italy.
  • Kowalski ML; Dept of Medicine, Unit for Heart and Lung disease, Karolinska Institutet, Stockholm, Sweden.
  • Patel J; ISGlobal, Barcelona, Spain.
  • Tan W; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Torén K; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Zuberbier T; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Dept of Population Health, University of Oxford, Oxford, UK.
  • Burney P; Dept of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.
  • Jarvis D; Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College London, London, UK.
Eur Respir J ; 54(3)2019 09.
Article en En | MEDLINE | ID: mdl-31221806
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Broncodilatadores / Enfermedad Pulmonar Obstructiva Crónica / Albuterol Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Año: 2019 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Broncodilatadores / Enfermedad Pulmonar Obstructiva Crónica / Albuterol Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Año: 2019 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido